Coherus Oncology, Inc. (CHRS) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Coherus Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:04.113 Good day and thank you for standing by. Welcome 00:00:04.113 -- 00:00:09.936 to the Q2 2026 Cohorus Oncology, Inc. Earnings Conference Call. 00:00:09.936 -- 00:00:14.458 At this time, all participants are in a listen-only mode. 00:00:14.458 -- 00:00:18.621 After the speaker's presentation, there will be a question and answer session. 00:00:18.621 -- 00:00:24.023 To ask a question during the session, you will need to press star 1, 00:00:24.023 -- 00:00:30.061 1 on your telephone. You will then hear an automated message advising your hand is raised. 00:00:30.061 -- 00:00:35.125 To withdraw your question, please press star 1, 1 again. 00:00:35.125 -- 00:00:38.969 Please be advised that today's conference is being recorded. 00:00:38.969 -- 00:00:43.353 I would now like to hand the conference over to your speaker today, Carrie Graham. 00:00:43.353 -- 00:00:44.293 Please go ahead. 00:00:44.293 -- 00:00:46.255 Thank 00:00:46.255 -- 00:00:50.859 you, Heidi. Good afternoon and welcome to Go Harris Oncology's second quarter 2026 earnings 00:00:50.859 -- 00:00:55.924 conference call. Joining me today to discuss our results are Denny Lanfear, 00:00:55.924 -- 00:01:01.416 Chief Executive Officer, Go Harris, Dr. Rosh Dias, Chief Medical Officer, Dr. 00:01:01.416 -- 00:01:06.139 Theresa Lavallee, Chief Scientific and Development Officer, Sameer Goregaoker, Chief 00:01:06.139 -- 00:01:10.761 Commercial Officer, and Bryan McMichael, Chief Financial Officer. 00:01:10.761 -- 00:01:14.582 Before we get started, I would like to remind you that today's call includes forward-looking 00:01:14.582 -- 00:01:19.764 statements regarding O'Hara's current expectations about future events. 00:01:19.764 -- 00:01:24.426 Actual results may vary significantly, and w...